Cleared Traditional

K905144 - ECLIPSE ICA GLUCOSE
(FDA 510(k) Clearance)

Jan 1991
Decision
50d
Days
Class 2
Risk

K905144 is an FDA 510(k) clearance for the ECLIPSE ICA GLUCOSE. This device is classified as a Hexokinase, Glucose (Class II - Special Controls, product code CFR).

Submitted by Biotope, Inc. (Redmond, US). The FDA issued a Cleared decision on January 4, 1991, 50 days after receiving the submission on November 15, 1990.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.

Submission Details

510(k) Number K905144 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 15, 1990
Decision Date January 04, 1991
Days to Decision 50 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary

Device Classification

Product Code CFR — Hexokinase, Glucose
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1345

Similar Devices — CFR Hexokinase, Glucose

All 144
Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutions
K253490 · Roche Diagnostics · Feb 2026
Glucose2
K252357 · Abbott Ireland · Oct 2025
cobas pure integrated solutions, Glucose HK Gen.3, ISE indirect Na for Gen.2, ONLINE DAT Methadone II, Elecsys TSH
K220134 · Roche Diagnostics · Sep 2022
Glucose HK Gen.3, ISE indirect Na for Gen.2, Elecsys TSH, cobas pro integrated solutions
K191899 · Roche Diagnostics · Aug 2019
ALINITY C GLUCOSE REAGENT KIT, ALINITY C SYSTEM
K170316 · Abbott Laboratories · Oct 2017
ELITech Clinical Systems GLUCOSE HK SL, ELITech Clinical Systems ELICAL 2, ELITech Clinical Systems ELITROL I and ELITROL II
K153644 · Elitechgroup · Sep 2016